Vascular Biogenics Ltd (VBLT) Stock Decreases -14.02% This Week; Should You Buy?
Friday, January 21, 2022 02:18 PM | InvestorsObserver Analysts
Mentioned in this article
Vascular Biogenics Ltd (VBLT) stock has fallen -44.92% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives VBLT stock a score of 31 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 8. VBLT's rank also includes a long-term technical score of 15. The fundamental score for VBLT is 70. In addition to the average rating from Wall Street analysts, VBLT stock has a mean target price of $5.88. This means analysts expect the stock to add 316.67% over the next 12 months.
VBLT has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on VBLT!
Vascular Biogenics Ltd (VBLT) stock is higher by 3.31% while the S&P 500 has fallen -0.93% as of 2:17 PM on Friday, Jan 21. VBLT has risen $0.04 from the previous closing price of $1.36 on volume of 276,429 shares. Over the past year the S&P 500 is up 15.25% while VBLT has fallen -44.92%. VBLT lost -$0.48 per share in the over the last 12 months.
Click Here to get the full Stock Report for Vascular Biogenics Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
